Thyroid function tests are the most commonly requested endocrine investigations in both primary and secondary care. Attention to detail is vital, as the appropriate interpretation may point to conditions other than thyroid disease itself. We describe two cases of hypopituitarism masquerading as borderline thyroid function tests.
Introduction
Hypopituitarism is a partial or complete insu⁄ciency of pituitary hormone secretion, which may result from disorders involving the pituitary gland, hypothalamus, or surrounding structures. It is usually a mixture of several hormonal de¢ciencies but, rarely, may involve all pituitary hormones. 1 Symptoms depend on the degree of hormone depletion and the rapidity of onset and are very similar to the symptoms of primary de¢ciency or hypofunctioning of target glands. Acute onset of hormone de¢ciency is usually associated with pituitary apoplexy, in other cases, however, the onset is insidious. The clinical presentation also varies considerably, depending upon the age of the patient and the speci¢c hormone de¢ciencies. Insidious onset of hypopituitarism usually causes a subtle and gradual decline in health, a decline frequently attributed to other medical conditions. Signs and symptoms may include myalgia, arthralgia, fatigue, headache, weight loss or gain, anorexia, nausea, vomiting, abdominal pain, altered consciousness, decreased secondary sexual characteristics, anaemia of chronic disease, and hypoglycaemia. Separate retrospective studies have shown that mortality is increased from 1.3-to 2.2-fold in hypopituitarism compared with age-and sex-matched cohorts. 2, 3 We present two cases of hypopituitarism with insidious onset that were originally identi¢ed by general practitioners (GPs) in primary care as 'primary hypothyroidism'.
Case reports Case 1
A 78-year-old man visited his GP complaining of lassitude and mild abdominal pain. The GP sent blood for measurement of urea, electrolytes, bone pro¢le and thyroid function tests and the results showed thyroid abnormalities in line with anterior pituitary dysfunction. This attracted the attention of the authorizing biochemist, and consequently cortisol was added to the test run. All results (listed in Table 1 ) con¢rmed a primary pituitary disease. The GP was informed and it was suggested the patient be referred to an endocrine clinic. Further review of his notes indicated no relevant past medical history and no regular medication. He was slightly anaemic (see haemoglobin and haematocrit). On referral to the endocrine clinic the patient disclosed that he had already been started on 100 mg thyroxine, but this was discontinued by the Consultant Endocrinologist. Clinical examination revealed features of hypogonadism (small testicles and little body hair). The blood pressure (BP) was 140/80. Results of further investigations --including short synacthen test (SST), 4 testosterone, insulin-like growth factor 1 (IGF1) and growth hormone (GH), folliclestimulating hormone (FSH) and prolactin --con¢rmed secondary hypogonadism and secondary hypothyroidism, as well as adrenocorticotropic hormone (ACTH) and GH de¢ciency. The patient was started on hydrocortisone with subsequent addition of thyroxine.Visual ¢eld assessment showed a moderate compression of the optic chiasm with marked visual ¢eld defect in the right eye. Magnetic resonance imaging (MRI) showed large non-functioning pituitary adenoma with suprasellar extension. The patient had a transphenoidal pituitary adenomectomy resulting in apparent decompression of the pituitary tumour, followed by external beam radiotherapy. Follow-up showed the optic nerve had been relieved of pressure although the patient remained hormone de¢cient.
Case 2
A 32-year-old woman had visited her GP on several occasions since giving birth to her second child eight months previously. The GP had sent blood samples to the local hospital for thyroid function tests. The information available to the hospital biochemist from preceding test request cards indicated vague symptoms. These included weight gain, joint pains, lethargy and amenorrhoea. In addition, the patient su¡ered with well-controlled epilepsy. The results that attracted the attention of the biochemist were those of the thyroid function tests, which were in line with secondary hypothyroidism ( Table 2 ). On the basis of thyroid function test results, the biochemist arranged for cortisol, prolactin, leutinizing hormone (LH) and FSH to be assayed from the same sample. As the results were consistent with anterior pituitary hypofunction, the GP was informed and arrangements made for rapid referral of the patient to an endocrinologist for further investigation. The patient's seizures were well controlled during pregnancy, and sodium valproate levels were within the therapeutic range.
At around 33 weeks gestation she had developed gestational hypertension (BP 140/80) and proteinuria of 0.9 g/day. She underwent emergency caesarean section at 41 weeks, due to concerns about the fetus, as indicated by suspicious cardiotocography. A healthy infant girl was delivered and the patient made an uneventful recovery. A de¢nite history of postpartum bleed was not recorded. However, she was extremely tired on third day postpartum and her haemoglobin had dropped from 11.9 g/dL (reference range 11.5--16.5) on the day of delivery to 7.1g/dL postpartum. She was transfused with two units of blood and was discharged ¢ve days postpartum to the care of her GP.
On referral to the Endocrine Clinic it was found that the patient had been started on thyroxine on the basis of earlier results. This was discontinued by the endocrinologist. Further investigations (Table 2) , including short SST, 4 testosterone, IGF1 and GH, FSH and prolactin, con¢rmed secondary hypogonadism, secondary hypothyroidism and ACTH de¢ciency. The preliminary diagnosis of Sheehan's syndrome was made, a rare complication following pregnancy. 5 Clinical evaluation showed full visual ¢elds to confrontation.
The patient was started on hydrocortisone and then thyroxine a few days later. MRI imaging showed unremarkable supra-sellar and para-sellar regions, which is not supportive of Sheehan's. However, there have been reports of normal pituitary imaging in patients with Sheehan's, 6, 7 suggesting factors other than ischaemia may also be implicated in the pathogenesis of the syndrome.
Discussion
There is increasing demand for thyroid functions tests from primary care. Figures from our laboratory show an annual increase of about10% in thyroid-stimulating hormone (TSH) requests in the past few years (increasing from 40,000 in 2002 to 51,500 in 2005). The attention to equivocal thyroid function tests, where TSH level may be within the reference range or even slightly raised accompanied with low FT4 and FT3 (secondary hypothyroidism) is vital in the diagnosis of the insidious onset of hypopituitarism. A recent report has suggested the incidence of hypothyroidism secondary to hypopitutitarism is signi¢cantly higher 8 than originally believed. 9 The ¢gure reported was 55 cases per million per year in the UK (95% con¢dence interval 36--81). 8 Hence the occurrence of complete or partial hypopituitarism is more common than once considered and it should be suspected under certain conditions. Once con¢rmed the underlying cause should be investigated. The subtlety and chronicity of symptomatology may be associated with the failure to recognize hypopituitarism. In hypopitutarism, de¢ciencies of corticotrophin and thyrotrophin may be the least common, and the secretion of gonadotropins and GH is more likely to be a¡ected, 1 However thyroid function tests are often the ¢rst line of investigation in the presence of vague symptoms. The diagnosis of central hypothyroidism requires, at minimum, the measurement of both serum free T4 and TSH. Serum free T4 is low, but serum TSH may be low, normal, or even paradoxically elevated due to increase of serum immunoreactive TSH with decreased biological activity. 10--12 Reduced biological activity has been in part attributed to abnormalities in glycosylation of theTSH subunits. 13 In addition, measurement of gonadotrophins, GH and cortisol, as add-on tests, can further elucidate the extent of pituitary dysfunction. Every e¡ort should be made to avoid thyroxine therapy before hydrocortisone is replaced in this group of patients, as the former (if started before hydrocortisone replacement) can exacerbate glucocorticoid de¢ciency 9, 14 and theoretically induce an adrenal crisis. Of note is that among studies on e¡ects of antiepileptic drugs on thyroid hormones, there are con£icting reports. Generally it is reported that there is an insig-ni¢cant to a slight increase in TSH, free T4 and free T3 after chronic treatment with valproic acid. 15 These two cases highlight the important role of the clinical biochemist. They demonstrate that approval by the biochemist of daily results is vital for identifying those rare cases arising from primary care which may present with borderline results. In both cases, additional investigations initiated by the authorizing biochemist led to rapid diagnosis of hypopituitarism and correct management of these patients.
